Art

J-GLOBAL ID：201902239550482752   Reference number：19A0788986

Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors

PD-1/PD-L1阻害剤の有効性を予測するバイオマーカー【JST・京大機械翻訳】

Author (7)： Yi Ming (Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China) ,  Jiao Dechao (Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China) ,  Xu Hanxiao (Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China) ,  Liu Qian (Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China) ,  Zhao Weiheng (Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China) ,  Han Xinwei (Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China) ,  Wu Kongming (Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China)
Material： Molecular Cancer (Web)
Volume： 17  Issue： 1  Page： 129  Publication year： 2018 
JST Material Number： U7336A  ISSN： 1476-4598  Document type： Article
Article type： 文献レビュー  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Abstract/Point： Programmed cell death protein ...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A0788986&from=J-GLOBAL&jstjournalNo=U7336A") }}

Thesaurus term： tumor immunity ,  immunotherapy ,  tumor cell ,  *biomarker ,  tumor ,  variation(biology) ,  enteric microbe ,  protein ,  human(primates) ,  *forecast ,  T cell ,  mismatch repair ,  *effectiveness
Semi thesaurus term： *CD274抗原 ,  難治性腫瘍 ,  *阻害剤 , 【Automatic Indexing@JST】

Author keywords (6)： PD-1/PD-L1 inhibitors ,  Predictive biomarkers ,  Tumor mutational burden ,  Microsatellite instability ,  Gut microbiota ,  Peripheral biomarker

JST classification (2)： Chemistry,biochemistry and pathology of tumors(=neoplasms)  (GE02030N) ,  Gene expression  (EC02040Q)

Reference (134)：

• Mol Cancer; Engineering chimeric antigen receptor-T cells for cancer treatment; B Ye, CM Stary, X Li, Q Gao, C Kang, X Xiong; 17; 2018; 32; 10.1186/s12943-018-0814-0; citation_id=CR1
• J Hematol Oncol; Chimeric antigen receptor T cells: a novel therapy for solid tumors; S Yu, A Li, Q Liu, T Li, X Yuan, X Han; 10; 2017; 78; 10.1186/s13045-017-0444-9; citation_id=CR2
• Exp Hematol Oncol; Development and clinical application of anti-HER2 monoclonal and bispecific antibodies for cancer treatment; S Yu, Q Liu, X Han, S Qin, W Zhao, A Li; 6; 2017; 31; 10.1186/s40164-017-0091-4; citation_id=CR3
• Expert Rev Clin Pharmacol; Atezolizumab in invasive and metastatic urothelial carcinoma; M Crist, A Balar; 10; 2017; 1295-1301; 10.1080/17512433.2017.1389275; citation_id=CR4
• J Clin Pathol; PD-L1; A Kythreotou, A Siddique, FA Mauri, M Bower, DJ Pinato; 71; 2018; 189-194; 10.1136/jclinpath-2017-204853; citation_id=CR5

Terms in the title (6)： PD-1 ,  PD-L1 ,  阻害剤 ,  有効性 ,  予測 ,  バイオマーカー